查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1830887

2025年核糖核酸（RNA）编辑全球市场报告

Ribonucleic Acid (RNA) Editing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，核糖核酸 (RNA) 编辑市场规模强劲成长，从 2024 年的 161 亿美元成长至 2025 年的 175.5 亿美元，复合年增长率为 9.0%。预测期内的成长动力包括：对瞬时和可逆 RNA 编辑方法的需求不断增长、其在神经退化性疾病研究中的应用不断拓展、罕见疾病和孤儿病患病率的上升、人们对合成生物学和生物技术的兴趣日益浓厚，以及学术和转化研究活动的不断活跃。

预计未来几年核糖核酸 (RNA) 编辑市场规模将强劲成长，到 2029 年将达到 244.2 亿美元，复合年增长率为 8.6%。预测期内的增长可归因于遗传疾病盛行率的上升、对个人化医疗的日益关注、癌症治疗应用的增多、递送系统的进步以及政府和监管机构日益增强的支持。这段时期的主要趋势包括 RNA 编辑平台的创新、体内递送技术的进步、定序和转录组学的进展、瞬时基因调控技术的发展以及合成生物学应用的不断拓展。

核糖核酸 (RNA) 编辑是一种转录后机制，它改变去氧核糖核酸(DNA) 转录成 RNA 分子后的碱基序列。这些修饰可以改变所生成蛋白质的结构和功能，进而影响基因表现并带来治疗潜力。

RNA编辑的主要类型包括传讯RNA(mRNA)修饰、转移RNA (tRNA)修饰和核醣体RNA (rRNA)修饰。传讯RNA修饰涉及转录后mRNA分子的化学变化，例如甲基化和核苷酸序列的改变。常见的修饰方式包括核苷酸插入、缺失和脱氨基。这些修饰已被应用于癌症、遗传性疾病和短暂性疾病的治疗。

2025年春季美国关税的突然上调及其引发的贸易摩擦正对製药公司造成严重衝击。高利润率的学名药製造商尤其容易受到影响，一些公司正在缩减低收益药品的生产。由于关税导致的专用试剂短缺，生物技术公司正面临临床试验延迟。为此，该产业正在印度和欧洲扩大原料药的生产，增加库存，并游说获得基本药物的贸易豁免。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供核糖核酸（RNA 编辑）市场统计数据，例如全球市场规模、区域份额、竞争对手的核糖核酸（RNA 编辑）市场份额、详细的核糖核酸（RNA 编辑）细分市场、市场趋势和机会，以及在核糖核酸（RNA 编辑）市场取得成功所需的数据。本核糖核酸（RNA 编辑）市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切资讯的完整观点。

遗传疾病的盛行率不断上升，推动了核糖核酸 (RNA) 编辑市场的成长。由遗传或自发性突变引起的遗传疾病正变得越来越普遍，部分原因是父母年龄的增长增加了染色体异常的可能性。 RNA 编辑可以透过在 RNA 层面上纠正突变来实现治疗，使细胞能够在不改变底层 DNA 的情况下产生功能性蛋白质。例如，截至 2024 年 5 月，美国约有 10 万人患有镰状细胞疾病，这表明对基于 RNA 的治疗方法的需求很高。

RNA编辑市场中的公司正在推进创新方法，例如体内基因编辑，它直接修改活细胞内的基因以纠正致病突变。 2024年4月，雷特氏症研究信託基金推出了MECP2编辑联盟，旨在开发针对雷特氏症遗传病因的RNA和DNA编辑疗法。该联盟汇集了六家领先研究机构的专业知识，旨在加速这种神经系统疾病精准且可能治癒的治疗方法的临床开发。

2025年5月，韩国生物製药公司Rznomics Inc.与礼来公司合作，开发一种用于治疗感音性听障的RNA编辑疗法。 Rznomics将利用其反式剪接核酶平台进行早期研究，而礼来公司则负责后期开发和全球商业化。此次合作凸显了对RNA编辑技术的持续投资，旨在为遗传疾病和罕见疾病提供标靶治疗。

核糖核酸 (RNA) 编辑市场由提供治疗性核糖核酸 (RNA) 编辑服务、核糖核酸 (RNA) 编辑递送优化、生物资讯学和数据分析服务的营业单位所获得的收益组成。市场价值还包括服务提供者销售的或包含在其服务产品中的相关产品的价值。核糖核酸 (RNA) 编辑市场还包括核糖核酸 (RNA) 编辑疗法、诊断套件和核糖核酸 (RNA) 编辑递送系统的销售。这是产品製造商或创造者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品的价值。该市场中的产品价值还包括产品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球核糖核酸（RNA 编译）市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球核糖核酸（RNA）编辑市场：成长率分析
  • 全球核糖核酸 (RNA) 编辑市场表现：规模与成长，2019-2024 年
  • 全球核糖核酸 (RNA) 编辑市场预测：规模与成长，2024-2029 年，2034 年
  • 全球核糖核酸 (RNA) 编辑：总目标市场 (TAM)

第六章 市场细分

  • 全球核糖核酸 (RNA) 编辑市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 信使核糖核酸（RNA）修饰
  • 转移核糖核酸（RNA）修饰
  • 核醣体核糖核酸（RNA）的修饰
  • 全球核糖核酸 (RNA) 编辑市场：按技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 插入或删除
  • 脱氨
  • 全球核糖核酸 (RNA) 编辑市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 癌症
  • 遗传性疾病
  • 暂时疾病
  • 全球核糖核酸 (RNA) 编辑市场：依信使核糖核酸 (RNA) (mRNA) 修饰细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 碱基编辑
  • 参与核糖核酸（RNA）介导的编辑的Adenosine deaminase
  • 定点核糖核酸（RNA）编辑
  • 全球核糖核酸 (RNA) 编辑市场：按转移核糖核酸 (RNA) (Trna) 修饰细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 假尿苷化
  • 转移RNA剪接
  • 肌苷修饰
  • 全球核糖核酸 (RNA) 编辑市场：细分：核醣体核糖核酸 (RNA) (RRNA) 修饰（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 假尿苷化
  • 核醣体RNA成熟途径的调控
  • 位点特异性核醣体核糖核酸（RNA）编辑

第七章 区域和国家分析

  • 全球核糖核酸 (RNA) 编辑市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球核糖核酸 (RNA) 编辑市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 核糖核酸（RNA）编辑市场：竞争格局
  • 核糖核酸（RNA）编辑市场：公司简介
    • Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Arcturus Therapeutics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • CureVac AG Overview, Products and Services, Strategy and Financial Analysis
    • Beam Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • EdiGene Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Ethris GmbH
  • Deep Genomics Incorporated
  • ProQR Therapeutics NV
  • ReCode Therapeutics
  • Capstan Therapeutics Inc.
  • TriLink BioTechnologies
  • ADARx Pharmaceuticals Inc.
  • Storm Therapeutics Limited
  • Ascidian Therapeutics Inc.
  • Rznomics Inc.
  • Airna Biotech SL
  • hC Bioscience Inc.
  • Korro Bio Inc.
  • Shape TX
  • Turn Biotechnologies

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年核糖核酸（RNA编辑）市场：提供新机会的国家
  • 2029年核糖核酸（RNA编辑）市场：细分领域带来新机会
  • 核糖核酸（RNA）编辑市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r37878

Ribonucleic acid (RNA) editing is a post-transcriptional mechanism that modifies the nucleotide sequence of RNA molecules after they are transcribed from deoxyribonucleic acid (DNA). These modifications can alter the structure or function of the resulting protein, thereby influencing gene expression and presenting potential therapeutic opportunities.

The primary types of RNA editing include messenger RNA (mRNA) modification, transfer RNA (tRNA) modification, and ribosomal RNA (rRNA) modification. Messenger RNA modification involves chemical alterations to mRNA molecules after transcription, such as methylation or nucleotide sequence changes. Common techniques include nucleotide insertion or deletion and deamination. These modifications have applications in treating conditions such as cancer, genetic disorders, and transient ailments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The ribonucleic acid (RNA) editing market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (RNA) editing market statistics, including the ribonucleic acid (RNA) editing industry's global market size, regional shares, competitors with the ribonucleic acid (RNA) editing market share, detailed ribonucleic acid (RNA) editing market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (RNA) editing market. This ribonucleic acid (RNA) editing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ribonucleic acid (RNA) editing market size has grown strongly in recent years. It will grow from $16.10 billion in 2024 to $17.55 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to the rising demand for transient and reversible RNA editing methods, expanding applications in neurodegenerative disease research, increasing prevalence of rare and orphan diseases, growing interest in synthetic biology and bioengineering, and heightened academic and translational research activities.

The ribonucleic acid (RNA) editing market size is expected to see strong growth in the next few years. It will grow to $24.42 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the rising prevalence of genetic disorders, expanding emphasis on personalized medicine, increasing applications in cancer therapy, advancements in delivery systems, and growing support from government and regulatory agencies. Major trends during this period include innovations in RNA editing platforms, progress in in vivo delivery technologies, advancements in sequencing and transcriptomics, development of transient gene modulation techniques, and expansion of synthetic biology applications.

The rising prevalence of genetic disorders is driving growth in the ribonucleic acid (RNA) editing market. Genetic disorders, caused by inherited or spontaneous mutations, are becoming more common partly due to increasing parental age, which raises the likelihood of chromosomal abnormalities. RNA editing enables treatment by correcting mutations at the RNA level, allowing cells to produce functional proteins without changing the underlying DNA. For example, as of May 2024, sickle cell disease affects approximately 100,000 people in the United States, illustrating the significant need for RNA-based therapeutic approaches.

Companies in the RNA editing market are advancing innovative approaches such as in vivo gene editing, which directly alters genes within living cells to correct disease-causing mutations. In April 2024, the Rett Syndrome Research Trust launched the MECP2 Editing Consortium to develop RNA and DNA editing therapies targeting the genetic causes of Rett syndrome. By combining expertise from six leading laboratories, the consortium aims to accelerate clinical development of precise, potentially curative treatments for this neurological disorder.

In May 2025, Rznomics Inc., a South Korea-based biopharmaceutical company, partnered with Eli Lilly and Company to develop RNA-editing therapies for sensorineural hearing loss. Rznomics is utilizing its trans-splicing ribozyme platform for early-stage research, while Eli Lilly manages later-stage development and global commercialization. This collaboration highlights the growing investment in RNA-editing technologies to deliver targeted therapies for genetic and rare diseases.

Major players in the ribonucleic acid (RNA) editing market are Moderna Inc., Arcturus Therapeutics Holdings Inc., CureVac AG, Beam Therapeutics Inc., EdiGene Inc., Ethris GmbH, Deep Genomics Incorporated, ProQR Therapeutics NV, ReCode Therapeutics, Capstan Therapeutics Inc., TriLink BioTechnologies, ADARx Pharmaceuticals Inc., Storm Therapeutics Limited, Ascidian Therapeutics Inc., Rznomics Inc., Airna Biotech S.L., hC Bioscience Inc., Korro Bio Inc., Shape TX, and Turn Biotechnologies.

North America was the largest region in the ribonucleic acid(RNA) editing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ribonucleic acid (RNA) editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ribonucleic acid (RNA) editing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ribonucleic acid (RNA) editing market consists of revenues earned by entities by providing services such as therapeutic ribonucleic acid (RNA) editing services, ribonucleic acid (RNA) editing delivery optimization, and bioinformatics and data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA) editing market also includes sales of ribonucleic acid (RNA) editing therapeutics, diagnostic kits, and ribonucleic acid (RNA) editing delivery systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ribonucleic Acid (RNA) Editing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ribonucleic acid (rna) editing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ribonucleic acid (rna) editing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) editing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Messenger Ribonucleic Acid (RNA) Modification; Transfer Ribonucleic Acid (RNA) Modification; Ribosomal Ribonucleic Acid (RNA) Modification
  • 2) By Technique: Insertion Or Deletion; Deamination
  • 3) By Application: Cancer; Genetic Disorders; Temporary Maladies
  • Subsegments:
  • 1) By Messenger Ribonucleic Acid(RNA) (Mrna) Modification: Base Editing; Adenosine Deaminase Acting On Ribonucleic Acid (RNA)-Mediated Editing; Site-Directed Ribonucleic Acid (RNA) Editing
  • 2) By Transfer Ribonucleic Acid (RNA) (Trna) Modification: Pseudouridylation; Transfer Ribonucleic Acid Splicing; Inosine Modification
  • 3) By Ribosomal Ribonucleic Acid (RNA) (Rrna) Modification: Pseudouridylation; Ribosomal Ribonucleic Acid (RNA) Maturation Pathway Modulation; Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing
  • Companies Mentioned: Moderna Inc.; Arcturus Therapeutics Holdings Inc.; CureVac AG; Beam Therapeutics Inc.; EdiGene Inc.; Ethris GmbH; Deep Genomics Incorporated; ProQR Therapeutics NV; ReCode Therapeutics; Capstan Therapeutics Inc.; TriLink BioTechnologies; ADARx Pharmaceuticals Inc.; Storm Therapeutics Limited; Ascidian Therapeutics Inc.; Rznomics Inc.; Airna Biotech S.L.; hC Bioscience Inc.; Korro Bio Inc.; Shape TX; Turn Biotechnologies.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ribonucleic Acid (RNA) Editing Market Characteristics

3. Ribonucleic Acid (RNA) Editing Market Trends And Strategies

4. Ribonucleic Acid (RNA) Editing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Ribonucleic Acid (RNA) Editing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Ribonucleic Acid (RNA) Editing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Ribonucleic Acid (RNA) Editing Market Growth Rate Analysis
  • 5.4. Global Ribonucleic Acid (RNA) Editing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Ribonucleic Acid (RNA) Editing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Ribonucleic Acid (RNA) Editing Total Addressable Market (TAM)

6. Ribonucleic Acid (RNA) Editing Market Segmentation

  • 6.1. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Messenger Ribonucleic Acid(RNA) Modification
  • Transfer Ribonucleic Acid(RNA) Modification
  • Ribosomal Ribonucleic Acid(RNA) Modification
  • 6.2. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insertion Or Deletion
  • Deamination
  • 6.3. Global Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer
  • Genetic Disorders
  • Temporary Maladies
  • 6.4. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Messenger Ribonucleic Acid(RNA) (Mrna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Base Editing
  • Adenosine Deaminase Acting On Ribonucleic Acid(RNA)-Mediated Editing
  • Site-Directed Ribonucleic Acid (RNA) Editing
  • 6.5. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Transfer Ribonucleic Acid(RNA) (Trna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pseudouridylation
  • Transfer Ribonucleic Acid Splicing
  • Inosine Modification
  • 6.6. Global Ribonucleic Acid (RNA) Editing Market, Sub-Segmentation Of Ribosomal Ribonucleic Acid(RNA) (Rrna) Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pseudouridylation
  • Ribosomal Ribonucleic Acid(RNA) Maturation Pathway Modulation
  • Site-Specific Ribosomal Ribonucleic Acid (RNA) Editing

7. Ribonucleic Acid (RNA) Editing Market Regional And Country Analysis

  • 7.1. Global Ribonucleic Acid (RNA) Editing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Ribonucleic Acid (RNA) Editing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ribonucleic Acid (RNA) Editing Market

  • 8.1. Asia-Pacific Ribonucleic Acid (RNA) Editing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ribonucleic Acid (RNA) Editing Market

  • 9.1. China Ribonucleic Acid (RNA) Editing Market Overview
  • 9.2. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ribonucleic Acid (RNA) Editing Market

  • 10.1. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ribonucleic Acid (RNA) Editing Market

  • 11.1. Japan Ribonucleic Acid (RNA) Editing Market Overview
  • 11.2. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ribonucleic Acid (RNA) Editing Market

  • 12.1. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ribonucleic Acid (RNA) Editing Market

  • 13.1. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ribonucleic Acid (RNA) Editing Market

  • 14.1. South Korea Ribonucleic Acid (RNA) Editing Market Overview
  • 14.2. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ribonucleic Acid (RNA) Editing Market

  • 15.1. Western Europe Ribonucleic Acid (RNA) Editing Market Overview
  • 15.2. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ribonucleic Acid (RNA) Editing Market

  • 16.1. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ribonucleic Acid (RNA) Editing Market

  • 17.1. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ribonucleic Acid (RNA) Editing Market

  • 18.1. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ribonucleic Acid (RNA) Editing Market

  • 19.1. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ribonucleic Acid (RNA) Editing Market

  • 20.1. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ribonucleic Acid (RNA) Editing Market

  • 21.1. Eastern Europe Ribonucleic Acid (RNA) Editing Market Overview
  • 21.2. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ribonucleic Acid (RNA) Editing Market

  • 22.1. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ribonucleic Acid (RNA) Editing Market

  • 23.1. North America Ribonucleic Acid (RNA) Editing Market Overview
  • 23.2. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ribonucleic Acid (RNA) Editing Market

  • 24.1. USA Ribonucleic Acid (RNA) Editing Market Overview
  • 24.2. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ribonucleic Acid (RNA) Editing Market

  • 25.1. Canada Ribonucleic Acid (RNA) Editing Market Overview
  • 25.2. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ribonucleic Acid (RNA) Editing Market

  • 26.1. South America Ribonucleic Acid (RNA) Editing Market Overview
  • 26.2. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ribonucleic Acid (RNA) Editing Market

  • 27.1. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ribonucleic Acid (RNA) Editing Market

  • 28.1. Middle East Ribonucleic Acid (RNA) Editing Market Overview
  • 28.2. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ribonucleic Acid (RNA) Editing Market

  • 29.1. Africa Ribonucleic Acid (RNA) Editing Market Overview
  • 29.2. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Ribonucleic Acid (RNA) Editing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ribonucleic Acid (RNA) Editing Market Competitive Landscape And Company Profiles

  • 30.1. Ribonucleic Acid (RNA) Editing Market Competitive Landscape
  • 30.2. Ribonucleic Acid (RNA) Editing Market Company Profiles
    • 30.2.1. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Arcturus Therapeutics Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. CureVac AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Beam Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. EdiGene Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Ribonucleic Acid (RNA) Editing Market Other Major And Innovative Companies

  • 31.1. Ethris GmbH
  • 31.2. Deep Genomics Incorporated
  • 31.3. ProQR Therapeutics NV
  • 31.4. ReCode Therapeutics
  • 31.5. Capstan Therapeutics Inc.
  • 31.6. TriLink BioTechnologies
  • 31.7. ADARx Pharmaceuticals Inc.
  • 31.8. Storm Therapeutics Limited
  • 31.9. Ascidian Therapeutics Inc.
  • 31.10. Rznomics Inc.
  • 31.11. Airna Biotech S.L.
  • 31.12. hC Bioscience Inc.
  • 31.13. Korro Bio Inc.
  • 31.14. Shape TX
  • 31.15. Turn Biotechnologies

32. Global Ribonucleic Acid (RNA) Editing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA) Editing Market

34. Recent Developments In The Ribonucleic Acid (RNA) Editing Market

35. Ribonucleic Acid (RNA) Editing Market High Potential Countries, Segments and Strategies

  • 35.1 Ribonucleic Acid (RNA) Editing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Ribonucleic Acid (RNA) Editing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Ribonucleic Acid (RNA) Editing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer